Section 3 - Neurobiology
Published online by Cambridge University Press: 19 October 2021
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Violence in Psychiatry , pp. 73 - 154Publisher: Cambridge University PressPrint publication year: 2016
References
References
Warburton, K. The new mission of forensic mental health systems: managing violence as a medial syndrome in an environment that balances treatment and safety. CNS Spectr. 2014 Oct; 19(5): 368–373. DOI: 10.1017/S109285291400025X.CrossRefGoogle Scholar
Stahl, SM, Morrissette, DA, Cummings, M, et al. The California Department of State Hospitals Violence Assessment and Treatment (CAL-VAT) guidelines. CNS Spectr. 2014; 19(5): 357–365. DOI: 10.1017/S109285291400376.CrossRefGoogle ScholarPubMed
Stahl, SM, Morrissette, DA, Citrome, L, et al. “Metaguidelines” for the management of patients with schizophrenia. CNS Spectr. 2013; 18(3): 150–162.CrossRefGoogle Scholar
Correll, CU. From receptor pharmacology to improved outcomes: individualising the selection, dosing, and switching of antipsychotics. Eur. Psychiatry. 2010; 25(Suppl. 2): S12–21.CrossRefGoogle ScholarPubMed
Davis, JM, Chen, N. Dose response and dose equivalence of antipsychotics. J. Clin. Psychopharmacol. 2004; 24(2): 192–208.CrossRefGoogle Scholar
Krakowski, MI, Kunz, M, Czobor, P, Volavka, J. Long-term high-dose neuroleptic treatment: who gets it and why? Hosp. Community Psychiatry. 1993; 44(7): 640–644.Google Scholar
Comai, S, Tau, M, Gobbi, G. The psychopharmacology of aggressive behavior: a translational approach: part 1:neurobiology. J. Clin. Psychopharmacol. 2012; 32(1): 83–94.CrossRefGoogle ScholarPubMed
Comai, S, Tau, M, Pavlovic, Z, Gobbi, G. The psychopharmacology of aggressive behavior: a translational approach: part 2: clinical studies using atypical antipsychotics, anticonvulsants, and lithium. J. Clin. Psychopharmacol. 2012; 32(2): 237–260.CrossRefGoogle ScholarPubMed
Citrome, L, Volavka, J. The psychopharmacology of violence: making sensible decisions. CNS Spectr. 2014 Oct; 19(5): 411–418. DOI: 10.1017/S109285291400054.CrossRefGoogle ScholarPubMed
Volavka, J, Czobor, P, Citrome, L, Van Dorn, RA. Effectiveness of antipsychotic drugs against hostility with schizophrenia in the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) study. CNS Spectr. 2014; 0(5): 374–381. DOI: 10.1017/S1092852913000849.CrossRefGoogle Scholar
Meyer, JM. A rational approach to employing high plasma levels of antipsychotics for violence associated with schizophrenia: case vignettes. CNS Spectr. 2014 Oct; 0(5): 432–438. DOI: 10.1017/S10928514000236.CrossRefGoogle Scholar
Morrissette, DA, Stahl, SM. Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy. CNS Spectr. 2014; 19(5). DOI: 10.1017/S1092852914000388.CrossRefGoogle ScholarPubMed
Stahl, SM. Emerging guidelines for the use of antipsychotic polypharmacy. Rev. Psiquiatr. Salud. Ment. 2013; 6(3): 97–100.CrossRefGoogle ScholarPubMed
Stahl, SM. Antipsychotic polypharmacy: never say never, but never say always. Acta Psychiatr. Scand. 2012; 125(5): 349–351.CrossRefGoogle Scholar
Morrissette, DA, Stahl, SM. Should high dose or very long-term antipsychotic monotherapy be considered before antipsychotic polypharmacy? In Ritsner, MS, ed. Polypharmacy in Psychiatric Practice, Volume 1: Multiple Medication Use Strategies. Heidelberg: Springer; 2013: 107–125.Google Scholar
Volavka, J, Citrome, L. Pathways to aggression in schizophrenia affect results of treatment. Schizophr. Bull. 2011; 37(5): 921–929.CrossRefGoogle ScholarPubMed
Volavka, J, Citrome, L. Heterogeneity of violence in schizophrenia and implications for long-term treatment. Int. J. Clin. Pract. 2008; 62(8): 1237–1245.CrossRefGoogle ScholarPubMed
Frogley, C, Taylor, D, Dickens, G, Picchioni, M. A systematic review of the evidence of clozapine’s antiaggressive effects. Int. J. Neuropsychopharmacol. 2012; 15(9): 1351–1371.CrossRefGoogle Scholar
Stilwell, EN, Yates, SE, Brahm, NC. Violence among persons diagnosed with schizophrenia: how pharmacists can help. Res. Social Adm. Pharm. 2011; 7(4): 421–429.CrossRefGoogle ScholarPubMed
Swanson, JW, Swartz, MS, Van Dorn, RA, et al. Comparison of antipsychotic medication effects on reducing violence in people with schizophrenia. Br. J .Psychiatry. 2008; 193(1): 37–43.CrossRefGoogle ScholarPubMed
Volavka, J, Czobor, P, Nolan, K, et al. Overt aggression and psychotic symptoms in patients with schizophrenia treated with clozapine, olanzapine, risperidone, or haloperidol. J. Clin. Psychopharmacol. 2004; 24(2): 225–228.CrossRefGoogle ScholarPubMed
Topiwala, A, Fazel, S. The pharmacological management of violence in schizophrenia: a structured review. Expert Rev. Neurother. 2011; 11(1): 53–63.CrossRefGoogle ScholarPubMed
Bourget, D, Labelle, A. Managing pathologic aggression in people with psychotic disorders. J. Psychiatry Neurosci. 2012; 37(2): E3–4.CrossRefGoogle ScholarPubMed
Citrome, L, Volavka, J. Pharmacological management of acute and persistent aggression in forensic psychiatry settings. CNS Drugs. 2011; 25(12): 1009–1021.CrossRefGoogle ScholarPubMed
Roh, D, Chang, JG, Kim, CH, et al. Antipsychotic polypharmacy and high-dose prescription in schizophrenia: a 5-year comparison. Aust. N. Z. J. Psychiatry. 2014; 48(1): 52–60.CrossRefGoogle ScholarPubMed
Barnes, TR, Paton, C. Antipsychotic polypharmacy in schizophrenia: benefits and risks. CNS Drugs. 2011; 25(5): 383–399.CrossRefGoogle ScholarPubMed
Fleischhacker, WW, Uchida, H. Critical review of antipsychotic polypharmacy in the treatment of schizophrenia. Int. J. Neuropsychopharmacol. Jul; 17(7): 1083–1093.CrossRefGoogle Scholar
Fujita, J, Nishida, A, Sakata, M, Noda, T, Ito, H. Excessive dosing and polypharmacy of antipsychotics caused by pro re nata in agitated patients with schizophrenia. Psychiatry Clin. Neurosci. 2013; 67(5): 345–351.CrossRefGoogle ScholarPubMed
Gallego, JA, Bonetti, J, Zhang, J, Kane, JM, Correll, CU. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and meta-regression of global and regional trends from the 1970s to 2009. Schizophr. Res. 2012; 138(1): 18–28.CrossRefGoogle ScholarPubMed
Lochmann van Bennekom, MW, Gijsman, HJ, Zitman, FG. Antipsychotic polypharmacy in psychotic disorders: a critical review of neurobiology, efficacy, tolerability and cost effectiveness. J. Psychopharmacol. 2013; 27(4): 327–336.CrossRefGoogle ScholarPubMed
Langle, G, Steinert, T, Weiser, P, et al. Effects of polypharmacy on outcome in patients with schizophrenia in routine psychiatric treatment. Acta Psychiatr. Scand. 2012; 125(5): 372–381.CrossRefGoogle ScholarPubMed
Essock, SM, Schooler, NR, Stroup, TS, et al. Effectiveness of switching from antipsychotic polypharmacy to monotherapy. Am. J. Psychiatry. 2011; 168(7): 702–708.CrossRefGoogle ScholarPubMed
Suzuki, T, Uchida, H, Tanaka, KF, et al. Revising polypharmacy to a single antipsychotic regimen for patients with chronic schizophrenia. Int. J. Neuropsychopharmacol. 2004; 7(2): 133–142.CrossRefGoogle ScholarPubMed
Stahl, SM, Grady, MM. A critical review of atypical antipsychotic utilization: comparing monotherapy with polypharmacy and augmentation. Curr. Med .Chem. 2004; 11(3): 313–327.CrossRefGoogle ScholarPubMed
Aggarwal, NK, Sernyak, MJ, Rosenheck, RA. Prevalence of concomitant oral antipsychotic drug use among patients treated with long-acting, intramuscular, antipsychotic medications. J. Clin. Psychopharmacol. 2012; 32(3): 323–328.CrossRefGoogle Scholar
Stahl, SM. The last Diagnostic and Statistical Manual (DSM): replacing our symptom-based diagnoses with a brain circuit-based classification of mental illnesses. CNS Spectr. 2013; 18(2): 65–68.CrossRefGoogle ScholarPubMed
Singh, JP, Serper, M, Reinharth, J, Fazel, S. Structured assessment of violence risk in schizophrenia and other psychiatric disorders: a systematic review of the validity, reliability, and item content of 10 available instruments. Schizophr. Bull. 2011; 37(5): 899–912.CrossRefGoogle ScholarPubMed
Nolan, KA, Czobor, P, Roy, BB, et al. Characteristics of assaultive behavior among psychiatric inpatients. Psychiatr. Serv. 2003; 54(7): 1012–1016.CrossRefGoogle ScholarPubMed
Abderhalden, C, Needham, I, Dassen, T, et al. Predicting inpatient violence using an extended version of the Brøset-Violence-Checklist: instrument development and clinical application. BMC Psychiatry. 2006; 6: 17.CrossRefGoogle ScholarPubMed
Quanbeck, CD, McDermott, BE, Lam, J, et al. Categorization of aggressive acts committed by chronically assaultive state hospital patients. Psychiatr. Serv. 2007; 58(4): 521–528.CrossRefGoogle Scholar
McDermott, BE, Holoyda, BJ. Assessment of aggression in inpatient settings. CNS Spectr. 2014 Oct; 0(5): 425–431. DOI: 10.1017/S1092852914000224.CrossRefGoogle Scholar
Monahan, J, Skeem, JL. The evolution of violence risk assessment. CNS Spectr. 2014 Oct; 0(5): 419–424. DOI: 10.1017/S1092852914000145.CrossRefGoogle Scholar
Stahl, SM, Morrissette, DA. Stahl’s Illustrated: Violence: Neural Circuits, Genetics and Treatment. Cambridge, UK: Cambridge University Press; 2014.CrossRefGoogle Scholar
Wehring, HJ, Carpenter, WT. Violence and schizophrenia. Schizophr. Bull. 2011; 37(5): 877–878.CrossRefGoogle Scholar
Song, H, Min, SK. Aggressive behavior model in schizophrenic patients. Psychiatry Res. 2009; 167(1–2): 58–65.CrossRefGoogle ScholarPubMed
Serper, M, Beech, DR, Harvey, PD, Dill, C. Neuropsychological and symptom predictors of aggression on the psychiatric inpatient service. J. Clin. Exp. Neuropsychol. 2008; 30(6): 700–709.CrossRefGoogle ScholarPubMed
Stahl, SM. Stahl’s Essential Psychopharmacology. 4th edn. New York: Cambridge University Press; 2013.Google Scholar
Siever, LJ. Neurobiology of aggression and violence. Am. J. Psychiatry. 2008; 165(4): 429–442.CrossRefGoogle ScholarPubMed
Nord, M, Farde, L. Antipsychotic occupancy of dopamine receptors in schizophrenia. CNS Neurosci. Ther. 2011; 17(2): 97–103.CrossRefGoogle Scholar
Mauri, MC, Volonteri, LS, Colasanti, A, et al. Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response. Clin. Pharmacokinet. 2007; 46(5): 359–388.CrossRefGoogle ScholarPubMed
Coccaro, EF, Sripada, CS, Yanowitch, RN, Phan, KL. Corticolimbic function in impulsive aggressive behavior. Biol. Psychiatry. 2011; 69(12): 1153–1159.CrossRefGoogle ScholarPubMed
Coccaro, EF, McCloskey, MS, Fitzgerald, DA, Phan, KL. Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biol. Psychiatry. 2007; 62(2): 168–178.CrossRefGoogle ScholarPubMed
Hoptman, MJ, Antonius, D. Neuroimaging correlates of aggression in schizophrenia: an update. Curr. Opin. Psychiatry. 2011; 24(2): 100–106.CrossRefGoogle ScholarPubMed
De Sanctis, P, Foxe, JJ, Czobor, P, et al. Early sensory-perceptual processing deficits for affectively valenced inputs are more pronounced in schizophrenia patients with a history of violence than in their non-violent peers. Soc. Cogn. Affect Neurosci. 2013; 8(6): 678–687.CrossRefGoogle ScholarPubMed
Kumari, V, Barkataki, I, Goswami, S, et al. Dysfunctional, but not functional, impulsivity is associated with a history of seriously violent behaviour and reduced orbitofrontal and hippocampal volumes in schizophrenia. Psychiatry Res. 2009; 173(1): 39–44.CrossRefGoogle Scholar
Coccaro, EF. Intermittent explosive disorder as a disorder of impulsive aggression for DSM-5. Am. J. Psychiatry. 2012; 169(6): 577–588.CrossRefGoogle ScholarPubMed
Haller, J. The neurobiology of abnormal manifestations of aggression—a review of hypothalamic mechanisms in cats, rodents, and humans. Brain Res. Bull. 2013; 93: 97–109.CrossRefGoogle Scholar
Kumari, V, Aasen, I, Taylor, P, et al. Neural dysfunction and violence in schizophrenia: an fMRI investigation. Schizophr. Res. 2006; 84(1): 144–164.CrossRefGoogle Scholar
Krakowski, MI, Czobor, P, Nolan, KA. Atypical antipsychotics, neurocognitive deficits, and aggression in schizophrenic patients. J. Clin. Psychopharmacol. 2008; 28(5): 485–493.CrossRefGoogle ScholarPubMed
Krakowski, MI, Czobor, P. Executive function predicts response to antiaggression treatment in schizophrenia: a randomized controlled trial. J. Clin. Psychiatry. 2012; 73(1): 74–80.CrossRefGoogle ScholarPubMed
Elie, D, Poirier, M, Chianetta, J, et al. Cognitive effects of antipsychotic dosage and polypharmacy: a study with the BACS in patients with schizophrenia and schizoaffective disorder. J. Psychopharmacol. 2010; 24(7): 1037–1044.CrossRefGoogle ScholarPubMed
Singh, JP, Volavka, J, Czobor, P, Van Dorn, RA. A metaanalysis of the Val158Met COMT polymorphism and violent behavior in schizophrenia. PloS One. 2012; 7(8): e43423.CrossRefGoogle Scholar
Pavlov, KA, Chistiakov, DA, Chekhonin, VP. Genetic determinants of aggression and impulsivity in humans. J. Appl. Genet. 2012; 53(1): 61–82.CrossRefGoogle Scholar
Rosell, DR, Thompson, JL, Slifstein, M, et al. Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol. Psychiatry. 2010; 67(12): 1154–1162.CrossRefGoogle ScholarPubMed
Winstanley, CA, Theobald, DE, Dalley, JW, Glennon, JC, Robbins, TW. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl). 2004; 176(3–4): 376–385.CrossRefGoogle ScholarPubMed
References
Tateno, A, Jorge, RE, Robinson, RG. Clinical correlates of aggressive behavior after traumatic brain injury. J. Neuropsychiatry Clin. Neurosci. 2003; 15(2): 155–160.CrossRefGoogle ScholarPubMed
Pardini, M, Krueger, F, Hodgkinson, C, et al. Prefrontal cortex lesions and MAO-A modulate aggression in penetrating traumatic brain injury. Neurology. 2011; 76(12): 1038–1045.CrossRefGoogle ScholarPubMed
Comai, S, Tau, M, Gobbi, G. The psychopharmacology of aggressive behavior: a translational approach: part 1: neurobiology. J. Clin. Psychopharmacol. 2012; 32(1): 83–94.CrossRefGoogle ScholarPubMed
Goedhard, LE, Stolker, JJ, Heerdink, ER, et al. Pharmacotherapy for the treatment of aggressive behavior in general adult psychiatry: a systematic review. J. Clin. Psychiatry. 2006; 67(7): 1013–1024.CrossRefGoogle ScholarPubMed
Tidey, JW, Miczek, KA. Effects of SKF 38393 and quinpirole on aggressive, motor and schedule-controlled behaviors in mice. Behav. Pharmacol. 1992; 3(6): 553–565.CrossRefGoogle ScholarPubMed
Rodríguez-Arias, M, Miňarro, J, Aguilar, MA, Pinazo, J, Simón, VM. Effects of risperidone and SCH 23390 on isolation-induced aggression in male mice. Eur. Neuropsychopharmacol. 1998; 8(2): 95–103.CrossRefGoogle Scholar
Aguilar, MA, Miňarro, J, Pérez-Iranzo, N, Simon, VM. Behavioral profile of raclopride in agonistic encounters between male mice. Pharmacol. Biochem. Behav. 1994; 47(3): 753–756.CrossRefGoogle ScholarPubMed
Miczek, KA, Tidey, JW. Amphetamines: aggressive and social behavior. In: Asghar, K, De Souza, E, eds. Pharmacology and Toxicology of Amphetamine and Related Designer Drugs. Washington, DC: National Institute on Drug Abuse; 1989: 68Y100.Google Scholar
Blader, JC, Pliszka, SR, Jensen, PS, Schooler, NR, Kafantaris, V. Stimulant-responsive and stimulant-refractory aggressive behavior among children with ADHD. Pediatrics. 2010; 126(4): 796–806.CrossRefGoogle ScholarPubMed
Huey, ED, Putnam, KT, Grafman, J. A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia. Neurology. 2006; 66(1): 17–22.CrossRefGoogle ScholarPubMed
Huey, ED, Garcia, C, Wassermann, EM, Tierney, MC, Grafman, J. Stimulant treatment of frontotemporal dementia in 8 patients. J. Clin. Psychiatry. 2008; 69(12): 1981–1982.CrossRefGoogle ScholarPubMed
Ko, JH, Monchi, O, Ptito, A, et al. Theta burst stimulation-induced inhibition of dorsolateral prefrontal cortex reveals hemispheric asymmetry in striatal dopamine release during a set-shifting task: a TMS-[(11)C]raclopride PET study. Eur. J. Neurosci. 2008; 28(10): 2147–2155.CrossRefGoogle Scholar
Strafella, AP, Paus, T, Barrett, J, Dagher, A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J. Neurosci. 2001; 21(15): RC157.CrossRefGoogle ScholarPubMed
Jaskiw, GE, Karoum, FK, Weinberger, DR. Persistent elevations in dopamine and its metabolites in the nucleus accumbens after mild subchronic stress in rats with ibotenic acid lesions of the medial prefrontal cortex. Brain Res. 1990; 534(1–2): 321–323.CrossRefGoogle ScholarPubMed
Seeman, P, Van Tol, HH. Dopamine receptor pharmacology. Trends Pharmacol. Sci. 1994; 15(7): 264–270.CrossRefGoogle ScholarPubMed
Volavka, J, Bilder, R, Nolan, K. Catecholamines and aggression: the role of COMT and MAO polymorphisms. Ann. N. Y. Acad. Sci. 2004; 1036: 393–398.CrossRefGoogle Scholar
Cohen, MX, Krohn-Grimberghe, A, Elger, CE, Weber, B. Dopamine gene predicts the brain’s response to dopaminergic drug. Eur. J. Neurosci. 2007; 26(12): 3652–3660.CrossRefGoogle ScholarPubMed
Raymont, V, Greathouse, A, Reding, K, et al. Demographic, structural and genetic predictors of late cognitive decline after penetrating head injury. Brain. 2008; 131(Pt 2): 543–558.CrossRefGoogle ScholarPubMed
Cummings, JL, Mega, M, Gray, K, et al. The Neuropsychiatric Inventory: comprehensive assessment of psychopathology in dementia. Neurology. 1994; 44(12): 2308–2314.CrossRefGoogle Scholar
Bremner, JD, Vermetten, E, Mazure, CM. Development and preliminary psychometric properties of an instrument for the measurement of childhood trauma: the Early Trauma Inventory. Depress. Anxiety. 2000; 12(1): 1–12.3.0.CO;2-W>CrossRefGoogle ScholarPubMed
Solomon, J, Raymont, V, Braun, A, Butman, JA, Grafman, J. User-friendly software for the analysis of brain lesions (ABLe). Comput. Methods Programs Biomed. 2007; 86(3): 245–254.CrossRefGoogle Scholar
Tzourio-Mazoyer, N, Landeau, B, Papathanassiou, D, et al. Automated anatomical labeling of activations in SPM using a macroscopic anatomical parcellation of the MNI MRI single-subject brain. Neuroimage. 2002; 15(1): 273–289.CrossRefGoogle Scholar
Koenigs, M, Huey, ED, Calamia, M, et al. Distinct regions of prefrontal cortex mediate resistance and vulnerability to depression. J. Neurosci. 2008; 28(47): 12,341–12,348.CrossRefGoogle ScholarPubMed
Hodgkinson, CA, Yuan, Q, Xu, K, et al. Addictions biology: haplotype-based analysis for 130 candidate genes on a single array. Alcohol Alcohol. 2008; 43(5): 505–515.CrossRefGoogle ScholarPubMed
Huang, W, Ma, JZ, Payne, TJ, et al. Significant association of DRD1 with nicotine dependence. Hum. Genet. 2008; 123(2): 133–140.CrossRefGoogle ScholarPubMed
Fukui, N, Suzuki, Y, Sugai, T, et al. Exploring functional polymorphisms in the dopamine receptor D2 gene using prolactin concentration in healthy subjects. Mol. Psychiatry. 2010; 16(4): 356–358.CrossRefGoogle ScholarPubMed
Hamidovic, A, Dlugos, A, Skol, A, Palmer, AA, de Wit, H. Evaluation of genetic variability in the dopamine receptor D2 in relation to behavioral inhibition and impulsivity/sensation seeking: an exploratory study with d-amphetamine in healthy participants. Exp, Clin. Psychopharmacol. 2009; 17(6): 374–383.CrossRefGoogle Scholar
Shih, JC, Chen, K, Ridd, MJ. Monoamine oxidase: from genes to behavior. Annu. Rev. Neurosci. 1999; 22(1): 197–217.CrossRefGoogle Scholar
Vijayraghavan, S, Wang, M, Birnbaum, SG, Williams, GV, Arnsten, AF. Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory. Nat. Neurosci. 2007; 10(3): 376–384.CrossRefGoogle ScholarPubMed
Floresco, SB. Prefrontal dopamine and behavioral flexibility: shifting from an “inverted-U” toward a family of functions. Front. Neurosci. 2013; 7: 62.CrossRefGoogle Scholar
Cools, R, Frank, MJ, Gibbs, SE, et al. Striatal dopamine predicts outcome-specific reversal learning and its sensitivity to dopaminergic drug administration. J. Neurosci. 2009; 29(5): 1538–1543.CrossRefGoogle ScholarPubMed
Knutson, B, Gibbs, SE. Linking nucleus accumbens dopamine and blood oxygenation. Psychopharmacology (Berl.). 2007; 191(3): 813–822.CrossRefGoogle ScholarPubMed
Scheres, A, Milham, MP, Knutson, B, Castellanos, FX. Ventral striatal hyporesponsiveness during reward anticipation in attention-deficit/hyperactivity disorder. Biol .Psychiatry. 2007; 61(5): 720–724.CrossRefGoogle ScholarPubMed
Couppis, MH, Kennedy, CH. The rewarding effect of aggression is reduced by nucleus accumbens dopamine receptor antagonism in mice. Psychopharmacology (Berl.). 2008; 197(3): 449–456.CrossRefGoogle Scholar
Zamboni, G, Huey, ED, Krueger, F, Nichelli, PF, Grafman, J. Apathy and disinhibition in frontotemporal dementia: insights into their neural correlates. Neurology. 2008; 71(10): 736–742.CrossRefGoogle ScholarPubMed
Takahata, R, Moghaddam, B. Target-specific glutamatergic regulation of dopamine neurons in the ventral tegmental area. J. Neurochem. 2000; 75(4): 1775–1778.CrossRefGoogle ScholarPubMed
Diekhof, EK, Nerenberg, L, Falkai, P, et al. Impulsive personality and the ability to resist immediate reward: an fMRI study examining interindividual differences in the neural mechanisms underlying self-control. Hum. Brain Mapp. 2012; 33(12): 2768–2784.CrossRefGoogle ScholarPubMed
Buckholtz, JW, Treadway, MT, Cowan, RL, et al. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat.. Neurosci. 2010; 13(4): 419–421.CrossRefGoogle ScholarPubMed
Plichta, MM, Scheres, A. Ventral-striatal responsiveness during reward anticipation in ADHD and its relation to trait impulsivity in the healthy population: a meta-analytic review of the fMRI literature. Neurosci. Biobehav. Rev. 2014; 38: 125–134.CrossRefGoogle ScholarPubMed
Wong, TM. Brain injury and aggression: can we get some help? Neurology. 2011; 76(12): 1032–1033.CrossRefGoogle ScholarPubMed
Fowler, SB, Hertzog, J, Wagner, BK. Pharmacological interventions for agitation in head-injured patients in the acute care setting. J. Neurosci. Nurs. 1995; 27(2): 119–123.CrossRefGoogle ScholarPubMed
Kline, AE, Massucci, JL, Zafonte, RD, et al. Differential effects of single versus multiple administrations of haloperidol and risperidone on functional outcome after experimental brain trauma. Crit. Care Med. 2007; 35(3): 919–924.CrossRefGoogle ScholarPubMed
Hoffman, AN, Cheng, JP, Zafonte, RD, Kline, AE. Administration of haloperidol and risperidone after neurobehavioral testing hinders the recovery of traumatic brain injury-induced deficits. Life Sci. 2008; 83(17–18): 602–607.CrossRefGoogle ScholarPubMed
de Almeida, J, Palacios, JM, Mengod, G. Distribution of 5-HT and DA receptors in primate prefrontal cortex: implications for pathophysiology and treatment. Prog. Brain Res. 2008; 172: 101–115.CrossRefGoogle ScholarPubMed
DeYoung, CG, Peterson, JB, Séguin, JR, et al. The dopamine D4 receptor gene and moderation of the association between externalizing behavior and IQ. Arch. Gen. Psychiatry. 2006; 63(12): 1410–1416.CrossRefGoogle ScholarPubMed
Bakermans-Kranenburg, MJ, van Ijzendoorn, MH, Caspers, K, Philibert, R. DRD4 genotype moderates the impact of parental problems on unresolved loss or trauma. Attach. Hum. Dev. 2011; 13(3): 253–269.CrossRefGoogle ScholarPubMed
References
Nolan, KA, Czobor, P, Roy, BB, et al. Characteristics of assaultive behavior among psychiatric inpatients. Psychiatr. Serv. 2003; 54(7): 1012–1016.CrossRefGoogle Scholar
Quanbeck, CD, McDermott, BE, Lam, J, et al. Categorization of aggressive acts committed by chronically assaultive state hospital patients. Psychiatr. Serv. 2007; 58(4): 521–528.CrossRefGoogle ScholarPubMed
Stahl, SM. Deconstructing violence as a medical syndrome: mapping psychotic, impulsive and predatory subtypes to malfunctioning brain circuits. CNS Spectr. 2014; 19(5): 357–365.CrossRefGoogle ScholarPubMed
Stahl, SM, Morrissette, DA. Stahl’s Illustrated: Violence: Neural Circuits, Genetics and Treatment. Cambridge, UK: Cambridge University Press; 2014.CrossRefGoogle Scholar
Stahl, SM, Morrissette, DA, Cummings, M, et al. The California Department of State Hospitals Violence Assessment and Treatment (CAL-VAT) guidelines. CNS Spectr. 2014; 19(5): 449–465.CrossRefGoogle ScholarPubMed
Dardashti, L, O’Day, J, Barsom, M, Schwartz, E, Proctor, G. Illustrative cases to support Cal-VAT guidelines. CNS Spectr. 2015; 20(3): 311–318. DOI: 10.1017/S1092852915000127.CrossRefGoogle ScholarPubMed
Morrissette, DA, Stahl, SM. Treating the violent patient with psychosis or impulsivity utilizing antipsychotic polypharmacy and high-dose monotherapy. CNS Spectr. 2014; 19(5): 439–448.CrossRefGoogle ScholarPubMed
Coccaro, E, Fanning, J, Phan, KL, Lee, R. Serotonin and impulsive aggression. CNS Spectr. 2015; 20(3): 295–302.CrossRefGoogle Scholar
Rosell, D, Siever, L. The neurobiology of violence. CNS Spectr. 2015; 20(3): 1–26.CrossRefGoogle Scholar
Grant, JE, Kim, SW. Brain circuitry of compulsivity and impulsivity. CNS Spectr. 2014; 19(1): 21–27.CrossRefGoogle ScholarPubMed
Fineberg, NA, Chamberlain, SR, Goudriaan, AE, et al. New developments in human neurocognition: clinical, genetic and brain imaging correlates of impulsivity and compulsivity. CNS Spectr. 2014; 19(1): 69–89.CrossRefGoogle ScholarPubMed
Berlin, GS, Hollander, E. Compulsivity, impulsivity, and the DSM 5 process. CNS Spectr. 2014; 19(1): 62–68.CrossRefGoogle Scholar
Stahl, SM, Grady, M. Stahl’s Illustrated: Substance Use and Impulsive Disorders. Cambridge, UK: Cambridge University Press; 2012.CrossRefGoogle Scholar
Everitt, BJ, Robbins, TW. Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat. Neurosci. 2005; 8(11): 1481–1489.CrossRefGoogle Scholar
Everitt, BJ, Robbins, TW. From ventral to dorsal striatum: devolving views of their roles in drug addiction. Neurosci. Biobehav. Rev. 2013; 37(9 Pt A): 1946–1954.CrossRefGoogle ScholarPubMed
Wyvell, CL, Berridge, KC. Intra-accumbens amphetamine increases the conditioned incentive salience of sucrose reward: enhancement of reward “wanting” without enhanced “liking” or response reinforcement. J. Neurosci. 2000; 20(21): 8122–8130.CrossRefGoogle ScholarPubMed
Volkow, ND, Wang, GJ, Baler, RD. Reward, dopamine and the control of food intake: implications for obesity. Trends Cogn. Sci. 2011; 15(1): 37–46.CrossRefGoogle Scholar
Bartholomew, N, Morgan, R. Co-morbid mental illness and criminalness: implications for housing and treatment. CNS Spectr. 2015; 20(3): 1–10.CrossRefGoogle Scholar
Felthous, A. The appropriateness of treating psychopathic disorders. CNS Spectr. 2015; 20(3): 182–189.CrossRefGoogle ScholarPubMed
Medalia, A, Opler, LA, Saperstein, AM. Integrating psychopharmacology and cognitive remediation to treat cognitive dysfunction in the psychotic disorders. CNS Spectr. 2014; 19(2): 115–120.CrossRefGoogle ScholarPubMed
Hooker, CI, Bruce, L, Fisher, M, et al. Neural activity during emotion recognition after combined cognitive plus social cognitive training in schizophrenia. Schizophr. Res. 2012; 139(1–3): 53–59.CrossRefGoogle Scholar
Stahl, SM. Stahl’s Essential Psychopharmacology. 4th edn. New York: Cambridge University Press; 2013.Google Scholar
McElroy, S, Hudson, JI, Mitchell, JE, et al. Efficacy and safety of lisdexamfetamine for treatment of adults with moderate to severe binge-eating disorder: a randomized clinical trial. JAMA Psychiatry. 2015; 72(3): 235–246.CrossRefGoogle ScholarPubMed
References
Compton, WM, Conway, KP, Stinson, FS, Colliver, JD, Grant, BF. Prevalence, correlates, and comorbidity of DSM-IV antisocial personality syndromes and alcohol and specific drug use disorders in the United States: results from the national epidemiologic survey on alcohol and related conditions. J. Clin. Psychiatry. 2005; 66(6): 677–685.CrossRefGoogle ScholarPubMed
Anderson, NE, Kiehl, KA. Psychopathy and aggression: when paralimbic dysfunction leads to violence. Curr. Top. Behav. Neurosci. 2014; 17: 369–393.CrossRefGoogle ScholarPubMed
Michaud, SG, Aynesworth, H. Ted Bundy: Conversations with a Killer. Irving, TX: Authorlink Press; 2000.Google Scholar
Macmillan, MB. An Odd Kind of Fame: Stories of Phineas Gage. Boston, MA: The MIT Press; 2002.Google Scholar
Harlow, JM. Passage of an iron rod through the head. Boston Medical and Surgical Journal. 1848; 39(20): 389–393.Google Scholar
Bigelow, HJ. Dr. Harlow’s case of recovery from the passage of an iron bar through the head. Am. J. Med. Sci. 1850; 20(39): 13–22.CrossRefGoogle Scholar
Harlow, JM. Recovery from the Passage of an Iron Bar through the Head. Boston: David Clapp & Son; 1869.Google Scholar
Van Horn, JD, Irimia, A, Torgerson, CM, et al. Mapping connectivity damage in the case of Phineas Gage. PLoS ONE. 2012; 7(5): e37454.CrossRefGoogle Scholar
Cleckley, HM. The Mask of Sanity: An Attempt to Clarify Some Issues about the So-Called Psychopathic Personality. 5th edn. Chicago: William A. Dolan; 1988.Google Scholar
Harpur, TJ, Hare, RD, Hakstain, AR. Two-factor conceptualization of psychopathy: construct validity and assessment implications. Psychol. Assess. 1989; 11(1): 6–17.CrossRefGoogle Scholar
Cooke, DJ, Michie, C, Skeem, J. Understanding the structure of the psychopathy checklist–revised: an exploration of methodological confusion. Br. J. Psychiatry Suppl. 2007; 49: s39–s50.CrossRefGoogle ScholarPubMed
Raine, A. The Psychopathology of Crime: Criminal Behavior as a Clinical Disorder. 1st edn. San Diego, CA: Academic Press; 1997.Google Scholar
Raine, A. Autonomic nervous system factors underlying disinhibited, antisocial, and violent behavior: biosocial perspectives and treatment implications. Ann. N. Y. Acad. Sci. 1996; 794: 46–59.CrossRefGoogle ScholarPubMed
Thompson, DF, Ramos, CL, Willett, JK. Psychopathy: clinical features, developmental basis and therapeutic challenges. J. Clin. Pharm. Ther. 2014; 39(5): 485–495.CrossRefGoogle ScholarPubMed
Perry, BD, Pollard, R, Blakely, T, Baker, WL, Vigilante, D. Childhood trauma, the neurobiology of adaptation and “use-dependent” development of the brain: how “states” become “traits.” Infant Mental Health Journal. 1995; 16(4): 271–291.3.0.CO;2-B>CrossRefGoogle Scholar
Byrd, AL, Manuck, SB. MAOA, childhood maltreatment, and antisocial behavior: meta-analysis of a gene-environment interaction. Biol. Psychiatry. 2014; 75(1): 9–17.CrossRefGoogle Scholar
Haberstick, BC, Lessem, JM, Hewitt, JK, et al. MAOA genotype, childhood maltreatment, and their interaction in the etiology of adult antisocial behaviors. Biol. Psychiatry. 2014; 75(1): 25–30.CrossRefGoogle ScholarPubMed
Moul, C, Dobson-Stone, C, Brennan, J, Hawes, D, Dadds, M. An exploration of the serotonin system in antisocial boys with high levels of callous-unemotional traits. PLoS ONE. 2013; 8(2): e56619.CrossRefGoogle ScholarPubMed
Kretschmer, T, Vitaro, F, Barker, ED. The association between peer and own aggression is moderated by the BDNF Val-Met polymorphism. J. Res. Adolesc. 2014; 24(1): 177–185.CrossRefGoogle ScholarPubMed
Smearman, EL, Winiarski, DA, Brennan, PA, Najman, J, Johnson, KC. Social stress and the oxytocin receptor gene interact to predict antisocial behavior in an at-risk cohort. Dev. Psychopathol. 2015; 27(1): 309–318. DOI: 10.1017/S0954579414000649.CrossRefGoogle Scholar
Frick, PJ. Extending the construct of psychopathy to youth: implications for understanding, diagnosing, and treating antisocial children and adolescents. Can. J. Psychiatry. 2009; 54(12): 803–812.CrossRefGoogle ScholarPubMed
Trebuchon, A, Bartolomei, F, McGonigal, A, Laguitton, V, Chauvel, P. Reversible antisocial behavior in ventromedial prefrontal lobe epilepsy. Epilepsy Behav. 2013; 29(2): 367–373.CrossRefGoogle ScholarPubMed
Venables, NC, Patrick, CJ. Reconciling discrepant findings for P3 brain response in criminal psychopathy through reference to the concept of externalizing proneness. Psychophysiology. 2014; 51(5): 427–436.CrossRefGoogle Scholar
Drislane, LE, Vaidyanathan, U, Patrick, CJ. Reduced cortical call to arms differentiates psychopathy from antisocial personality disorder. Psychol. Medicine. 2013; 43(4): 825–835.CrossRefGoogle ScholarPubMed
Yoder, KJ, Decety, J. Spatiotemporal neural dynamics of moral judgment: a high-density ERP study. Neuropsychologia. 2014; 60: 39–45.CrossRefGoogle ScholarPubMed
Hyde, LW, Byrd, AL, Votruba-Drzal, E, Hariri, AR, Manuck, SB. Amygdala reactivity and negative emotionality: divergent correlates of antisocial personality and psychopathy traits in a community sample. J. Abnorm. Psychol. 2014; 123(1): 214–224.CrossRefGoogle Scholar
Decety, J, Skelly, L, Yoder, KJ, Kiehl, KA. Neural processing of dynamic emotional facial expressions in psychopaths. Soc. Neurosci. 2014; 9(1): 36–49.CrossRefGoogle ScholarPubMed
Ermer, E, Cope, LM, Nyalakanti, PK, Calhoun, VD, Kiehl, KA. Aberrant paralimbic gray matter in criminal psychopathy. J. Abnorm. Psychol. 2012; 121(3): 649–658.CrossRefGoogle ScholarPubMed
Shenhav, A, Greene, JD. Integrative moral judgment: dissociating the roles of the amygdala and ventromedial prefrontal cortex. J. Neurosci. 2014; 34(13): 4741–4749.CrossRefGoogle ScholarPubMed
Motzkin, JC, Newman, JP, Kiehl, KA, Koenigs, M. Reduced prefrontal connectivity in psychopathy. J. Neurosci. 2011; 31(48): 17,348–17,357.CrossRefGoogle ScholarPubMed
Contreras-Rodríguez, O, Pujol, J, Batalla, I, et al. Functional connectivity bias in the prefrontal cortex of psychopaths. Biol. Psychiatry. 2015; 78(9): 647–655. DOI: 10.1016/j.biopsych.2014.03.007.CrossRefGoogle ScholarPubMed
Li, W, Mai, X, Liu, C. The default mode network and social understanding of others: what do brain connectivity studies tell us? Front. Hum. Neurosci. 2014; 8: 74.CrossRefGoogle Scholar
Raine, A, Lencz, T, Taylor, K, et al. Corpus callosum abnormalities in psychopathic antisocial individuals. Arch. Gen. Psychiatry. 2003; 60(11): 1134–1142.CrossRefGoogle ScholarPubMed
Sundram, F, Deeley, Q, Sarkar, S, et al. White matter microstructural abnormalities in the frontal lobe of adults with antisocial personality disorder. Cortex. 2012; 48(2): 216–229.CrossRefGoogle ScholarPubMed
Gregory, S, Ffytche, D, Simmons, A, et al. The antisocial brain: psychopathy matters: a structural MRI investigation of antisocial male violent offenders. JAMA Psychiatry. 2012; 69(9): 962–972.Google Scholar
Haker, H, Schimansky, J, Rossler, W. [Sociophysiology: basic processes of empathy]. Neuropsychiatrie. 2010; 24(3): 151–160.Google ScholarPubMed
Cai, X, Padoa-Schioppa, C. Neuronal encoding of subjective value in dorsal and ventral anterior cingulate cortex. J. Neurosci. 2012; 32(11): 3791–3808.CrossRefGoogle ScholarPubMed
Buckholtz, JW, Treadway, MT, Cowan, RL, et al. Mesolimbic dopamine reward system hypersensitivity in individuals with psychopathic traits. Nat. Neurosci. 2010; 13(4): 419–421.CrossRefGoogle ScholarPubMed
Hare, RD, Neumann, CS. Psychopathy as a clinical and empirical construct. Ann. Rev. Clin. Psychol. 2008; 4: 217–246.CrossRefGoogle Scholar
Coid, JW. Personality disorders in prisoners and their motivation for dangerous and disruptive behaviour. Crim. Behav. Ment. Health. 2002; 12(3): 209–226.CrossRefGoogle ScholarPubMed
Sobral, J, Luengo, A, Gómez-Fraguela, JA, Romero, E, Villar, P. [Personality, gender and violent criminality in prison inmates]. Psicothema. 2007; 19(2): 269–275.Google ScholarPubMed
Endrass, J, Urbaniok, F, Gerth, J, Rossegger, A. [Prison violence: prevalence, manifestation and risk factors]. Praxis (Bern 1994). 2009; 98(22): 1279–1283.CrossRefGoogle Scholar
Kennedy, HG. Therapeutic uses of security: mapping forensic mental health services by stratifying risk. Advances in Psychiatric Treatment. 2002; 8(6): 433–443.CrossRefGoogle Scholar
Meffert, H, Gazzola, V, den Boer, JA, Bartels, AA, Keysers, C. Reduced spontaneous but relatively normal deliberate vicarious representations in psychopathy. Brain. 2013; 136(8): 2550–2562.CrossRefGoogle ScholarPubMed
Bonta, J, Andrews, DA. Risk-Need-Responsivity Model for Offender Assessment and Rehabilitation 2007–06. Ottawa: Her Majesty the Queen in Right of Canada; 2007.Google Scholar
Gitlin, MJ. Pharmacotherapy of personality disorders: conceptual framework and clinical strategies. J. Clin. Psychopharmacol. 1993; 13(5): 343–353.CrossRefGoogle ScholarPubMed
Citrome, L, Volavka, J. Pharmacological management of acute and persistent aggression in forensic psychiatry settings. CNS Drugs. 2011; 25(12): 1009–1021.CrossRefGoogle ScholarPubMed
Ripoll, LH, Triebwasser, J, Siever, LJ. Evidence-based pharmacotherapy for personality disorders. Int. J. Neuropsychopharmacol. 2011; 14(9): 1257–1288.CrossRefGoogle ScholarPubMed
Tupin, JP, Smith, DB, Clanon, TL, et al. The long-term use of lithium in aggressive prisoners. Compr. Psychiatry. 1973; 14(4): 311–317.CrossRefGoogle ScholarPubMed
Dunlop, BW, DeFife, JA, Marx, L, et al. The effects of sertraline on psychopathic traits. Int. Clin. Psychopharmacol. 2011; 26(6): 329–337.CrossRefGoogle ScholarPubMed
Brown, D, Larkin, F, Sengupta, S, et al. Clozapine: an effective treatment for seriously violent and psychopathic men with antisocial personality disorder in a UK high-security hospital. CNS Spectr. 2014; 19(5): 391–402.CrossRefGoogle Scholar
Bari, A, Niu, T, Langevin, JP, Fried, I. Limbic neuromodulation: implications for addiction, posttraumatic stress disorder, and memory. Neurosurg. Clin. N. Am. 2014; 25(1): 137–145.CrossRefGoogle ScholarPubMed
References
Hall, JE, Simon, TR, Lee, RD, Mercy, JA. Implications of direct protective factors for public health research and prevention strategies to reduce youth violence. Am. J. Prev. Med. 2012; 43(2 Suppl 1): S76–S83.CrossRefGoogle ScholarPubMed
Modi, MN, Palmer, S, Armstrong, A. The role of Violence Against Women Act in addressing intimate partner violence: a public health issue. J. Womens Health (Larchmt). 2014; 23(3): 253–259.CrossRefGoogle Scholar
Ramsay, SE, Bartley, A, Rodger, AJ. Determinants of assault-related violence in the community: potential for public health interventions in hospitals. Emerg. Med. J. 2014; 31: 986–989.CrossRefGoogle ScholarPubMed
Whitaker, S. Preventing violent conflict: a revised mandate for the public health professional? J. Public Health Policy. 2013; 34(1): 46–54.CrossRefGoogle ScholarPubMed
Bushman, BJ, Anderson, CA. Is it time to pull the plug on the hostile versus instrumental aggression dichotomy? Psychol. Rev. 2001; 108(1): 273–279.CrossRefGoogle Scholar
Baker, LA, Raine, A, Liu, J, Jacobson, KC. Differential genetic and environmental influences on reactive and proactive aggression in children. J. Abnorm. Child Psychol. 2008; 36(8): 1265–1278.CrossRefGoogle ScholarPubMed
Bezdjian, S, Tuvblad, C, Raine, A, Baker, LA. The genetic and environmental covariation among psychopathic personality traits, and reactive and proactive aggression in childhood. Child Dev. 2011; 82(4): 1267–1281.CrossRefGoogle ScholarPubMed
Cima, M, Raine, A, Meesters, C, Popma, A. Validation of the Dutch Reactive Proactive Questionnaire (RPQ): differential correlates of reactive and proactive aggression from childhood to adulthood. Aggress. Behav. 2013; 39(2): 99–113.CrossRefGoogle Scholar
Fossati, A, Raine, A, Borroni, S, et al. A cross-cultural study of the psychometric properties of the Reactive-Proactive Aggression Questionnaire among Italian nonclinical adolescents. Psychol. Assess. 2009; 21(1): 131–135.CrossRefGoogle ScholarPubMed
Fung, AL, Raine, A, Gao, Y. Cross-cultural generalizability of the Reactive-Proactive Aggression Questionnaire (RPQ). J. Pers. Assess. 2009; 91(5): 473–479.CrossRefGoogle Scholar
Raine, A, Dodge, K, Loeber, R, et al. The Reactive-Proactive Aggression Questionnaire: differential correlates of reactive and proactive aggression in adolescent boys. Aggress .Behav. 2006; 32(2): 159–171.CrossRefGoogle ScholarPubMed
Gardner, KJ, Archer, J, Jackson, S. Does maladaptive coping mediate the relationship between borderline personality traits and reactive and proactive aggression? Aggress. Behav. 2012; 38(5): 403–413.CrossRefGoogle ScholarPubMed
Lobbestael, J, Cima, M, Arntz, A. The relationship between adult reactive and proactive aggression, hostile interpretation bias, and antisocial personality disorder. J. Pers. Disord. 2013; 27(1): 53–66.CrossRefGoogle ScholarPubMed
Dodge, KA, Lochman, JE, Harnish, JD, Bates, JE, Pettit, GS. Reactive and proactive aggression in school children and psychiatrically impaired chronically assaultive youth. J. Abnorm. Psychol. 1997; 106(1): 37–51.CrossRefGoogle ScholarPubMed
Kolla, NJ, Malcolm, C, Attard, S, et al. Childhood maltreatment and aggressive behaviour in violent offenders with psychopathy. Can. J. Psychiatry. 2013; 58(8): 487–494.CrossRefGoogle ScholarPubMed
Arsenio, WF, Adams, E, Gold, J. Social information processing, moral reasoning, and emotion attributions: relations with adolescents’ reactive and proactive aggression. Child Dev. 2009; 80(6): 1739–1755.CrossRefGoogle Scholar
Crick, NR, Dodge, KA. Social information-processing mechanisms in reactive and proactive aggression. Child Dev. 1996; 67(3): 993–1002.CrossRefGoogle Scholar
Dodge, KA, Coie, JD. Social-information-processing factors in reactive and proactive aggression in children’s peer groups. J. Pers. Soc. Psychol. 1987; 53(6): 1146–1158.CrossRefGoogle ScholarPubMed
Hubbard, JA, Dodge, KA, Cillessen, AH, Coie, JD, Schwartz, D. The dyadic nature of social information processing in boys’ reactive and proactive aggression. J. Pers. Soc. Psychol. 2001; 80(2): 268–280.CrossRefGoogle ScholarPubMed
Smithmyer, CM, Hubbard, JA, Simons, RF. Proactive and reactive aggression in delinquent adolescents: relations to aggression outcome expectancies. J. Clin. Child Psychol. 2000; 29(1): 86–93.CrossRefGoogle ScholarPubMed
Walters, GD. Measuring proactive and reactive criminal thinking with the PICTS: correlations with outcome expectancies and hostile attribution biases. J. Interpers. Violence. 2007; 22(4): 371–385.CrossRefGoogle ScholarPubMed
Brugman, S, Lobbestael, J, Arntz, A, et al. Identifying cognitive predictors of reactive and proactive aggression. Aggress. Behav. 2014; 41: 51–64. DOI: 10.1002/AB.21573.CrossRefGoogle Scholar
Coccaro, EF, Kavoussi, RJ, Berman, ME, Lish, JD. Intermittent explosive disorder–revised: development, reliability, and validity of research criteria. Compr. Psychiatry. 1998; 39(6): 368–376.CrossRefGoogle ScholarPubMed
McCloskey, MS, Berman, ME, Noblett, KL, Coccaro, EF. Intermittent explosive disorder-integrated research diagnostic criteria: convergent and discriminant validity. J. Psychiatr. Res. 2006; 40(3): 231–242.CrossRefGoogle ScholarPubMed
Coccaro, EF. Intermittent explosive disorder: development of integrated research criteria for Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition. Compr. Psychiatry. 2011; 52(2): 119–125.CrossRefGoogle ScholarPubMed
Coccaro, EF, Lee, R, Kavoussi, RJ. Aggression, suicidality, and intermittent explosive disorder: serotonergic correlates in personality disorder and healthy control subjects. Neuropsychopharmacology. 2010; 35(2): 435–444.CrossRefGoogle ScholarPubMed
Salzman, CD, Fusi, S. Emotion, cognition, and mental state representation in amygdala and prefrontal cortex. Annu. Rev. Neurosci. 2010; 33: 173–202.CrossRefGoogle ScholarPubMed
Fernando, AB, Murray, JE, Milton, AL. The amygdala: securing pleasure and avoiding pain. Front. Behav. Neurosci. 2013; 7: 190.CrossRefGoogle ScholarPubMed
Sah, P, Faber, ES, Lopez De, AM, Power, J. The amygdaloid complex: anatomy and physiology. Physiol. Rev. 2003; 83(3): 803–834.CrossRefGoogle ScholarPubMed
John, YJ, Bullock, D, Zikopoulos, B, Barbas, H. Anatomy and computational modeling of networks underlying cognitive-emotional interaction. Front. Hum. Neurosci. 2013; 7: 101.CrossRefGoogle ScholarPubMed
Lee, S, Kim, SJ, Kwon, OB, Lee, JH, Kim, JH. Inhibitory networks of the amygdala for emotional memory. Front. Neural. Circuits. 2013; 7: 129.CrossRefGoogle ScholarPubMed
Bzdok, D, Laird, AR, Zilles, K, Fox, PT, Eickhoff, SB. An investigation of the structural, connectional, and functional subspecialization in the human amygdala. Hum. Brain Mapp. 2013; 34(12): 3247–3266.CrossRefGoogle ScholarPubMed
Matthies, S, Rusch, N, Weber, M, et al. Small amygdala-high aggression? The role of the amygdala in modulating aggression in healthy subjects. World J. Biol. Psychiatry. 2012; 13(1): 75–81.CrossRefGoogle ScholarPubMed
Pardini, DA, Raine, A, Erickson, K, Loeber, R. Lower amygdala volume in men is associated with childhood aggression, early psychopathic traits, and future violence. Biol. Psychiatry. 2014; 75(1): 73–80.CrossRefGoogle ScholarPubMed
Gopal, A, Clark, E, Allgair, A, et al. Dorsal/ventral parcellation of the amygdala: relevance to impulsivity and aggression. Psychiatry Res. 2013; 211(1): 24–30.CrossRefGoogle ScholarPubMed
Bobes, MA, Ostrosky, F, Diaz, K, et al. Linkage of functional and structural anomalies in the left amygdala of reactive-aggressive men. Soc. Cogn. Affect. Neurosci. 2013; 8(8): 928–936.CrossRefGoogle ScholarPubMed
Dyck, M, Loughead, J, Kellermann, T, et al. Cognitive versus automatic mechanisms of mood induction differentially activate left and right amygdala. Neuroimage. 2011; 54(3): 2503–2513.CrossRefGoogle ScholarPubMed
New, AS, Hazlett, EA, Newmark, RE, et al. Laboratory induced aggression: a positron emission tomography study of aggressive individuals with borderline personality disorder. Biol. Psychiatry. 2009; 66(12): 1107–1114.CrossRefGoogle ScholarPubMed
Coccaro, EF, McCloskey, MS, Fitzgerald, DA, Phan, KL. Amygdala and orbitofrontal reactivity to social threat in individuals with impulsive aggression. Biol. Psychiatry. 2007; 62(2): 168–178.CrossRefGoogle ScholarPubMed
Lozier, LM, Cardinale, EM, Vanmeter, JW, Marsh, AA. Mediation of the relationship between callous-unemotional traits and proactive aggression by amygdala response to fear among children with conduct problems. JAMA Psychiatry. 2014; 71(6): 627–636.CrossRefGoogle ScholarPubMed
Walton, ME, Croxson, PL, Behrens, TE, Kennerley, SW, Rushworth, MF. Adaptive decision making and value in the anterior cingulate cortex. Neuroimage. 2007; 36(Suppl 2): T142–T154.CrossRefGoogle ScholarPubMed
Rudebeck, PH, Murray, EA. The orbitofrontal oracle: cortical mechanisms for the prediction and evaluation of specific behavioral outcomes. Neuron. 2014; 84(6): 1143–1156.CrossRefGoogle ScholarPubMed
Gansler, DA, McLaughlin, NC, Iguchi, L, et al. A multivariate approach to aggression and the orbital frontal cortex in psychiatric patients. Psychiatry Res. 2009; 171(3): 145–154.CrossRefGoogle ScholarPubMed
Antonucci, AS, Gansler, DA, Tan, S, et al. Orbitofrontal correlates of aggression and impulsivity in psychiatric patients. Psychiatry Res. 2006; 147(2–3): 213–220.CrossRefGoogle ScholarPubMed
Boes, AD, Tranel, D, Anderson, SW, Nopoulos, P. Right anterior cingulate: a neuroanatomical correlate of aggression and defiance in boys. Behav. Neurosci. 2008; 122(3): 677–684.CrossRefGoogle ScholarPubMed
Ducharme, S, Hudziak, JJ, Botteron, KN, et al. Right anterior cingulate cortical thickness and bilateral striatal volume correlate with child behavior checklist aggressive behavior scores in healthy children. Biol .Psychiatry. 2011; 70(3): 283–290.CrossRefGoogle ScholarPubMed
Soloff, PH, Meltzer, CC, Greer, PJ, Constantine, D, Kelly, TM. A fenfluramine-activated FDG-PET study of borderline personality disorder. Biol. Psychiatry. 2000; 47(6): 540–547.CrossRefGoogle ScholarPubMed
New, AS, Hazlett, EA, Buchsbaum, MS, et al. Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. Arch. Gen. Psychiatry. 2002; 59(7): 621–629.CrossRefGoogle ScholarPubMed
Ghashghaei, HT, Hilgetag, CC, Barbas, H. Sequence of information processing for emotions based on the anatomic dialogue between prefrontal cortex and amygdala. Neuroimage. 2007; 34(3): 905–923.CrossRefGoogle ScholarPubMed
Timbie, C, Barbas, H. Specialized pathways from the primate amygdala to posterior orbitofrontal cortex. J. Neurosci. 2014; 34(24): 8106–8118.CrossRefGoogle ScholarPubMed
Ghashghaei, HT, Barbas, H. Pathways for emotion: interactions of prefrontal and anterior temporal pathways in the amygdala of the rhesus monkey. Neuroscience. 2002; 115(4): 1261–1279.CrossRefGoogle ScholarPubMed
Roy, AK, Shehzad, Z, Margulies, DS, et al. Functional connectivity of the human amygdala using resting state fMRI. Neuroimage. 2009; 45(2): 614–626.CrossRefGoogle ScholarPubMed
Hoptman, MJ, D’Angelo, D, Catalano, D, et al. Amygdalofrontal functional disconnectivity and aggression in schizophrenia. Schizophr. Bull. 2010; 36(5): 1020–1028.CrossRefGoogle Scholar
Fulwiler, CE, King, JA, Zhang, N. Amygdala-orbitofrontal restingstate functional connectivity is associated with trait anger. Neuroreport. 2012; 23(10): 606–610.CrossRefGoogle Scholar
Beyer, F, Munte, TF, Wiechert, J, Heldmann, M, Kramer, UM. Trait aggressiveness is not related to structural connectivity between orbitofrontal cortex and amygdala. PLoS One. 2014; 9(6): e101105.CrossRefGoogle Scholar
New, AS, Hazlett, EA, Buchsbaum, MS, et al. Amygdala-prefrontal disconnection in borderline personality disorder. Neuropsychopharmacology. 2007; 32(7): 1629–1640.CrossRefGoogle ScholarPubMed
Hornboll, B, Macoveanu, J, Rowe, J, et al. Acute serotonin 2A receptor blocking alters the processing of fearful faces in the orbitofrontal cortex and amygdala. J. Psychopharmacol. 2013; 27(10): 903–914.CrossRefGoogle ScholarPubMed
Rosell, DR, Thompson, JL, Slifstein, M, et al. Increased serotonin 2A receptor availability in the orbitofrontal cortex of physically aggressive personality disordered patients. Biol. Psychiatry. 2010; 67(12): 1154–1162.CrossRefGoogle ScholarPubMed
Passamonti, L, Crockett, MJ, Apergis-Schoute, AM, et al. Effects of acute tryptophan depletion on prefrontal-amygdala connectivity while viewing facial signals of aggression. Biol. Psychiatry. 2012; 71(1): 36–43.CrossRefGoogle Scholar
Pezawas, L, Meyer-Lindenberg, A, Drabant, EM, et al. 5-HTTLPR polymorphism impacts human cingulate-amygdala interactions: a genetic susceptibility mechanism for depression. Nat. Neurosci. 2005; 8(6): 828–834.CrossRefGoogle ScholarPubMed
Heinz, A, Braus, DF, Smolka, MN, et al. Amygdala-prefrontal coupling depends on a genetic variation of the serotonin transporter. Nat. Neurosci. 2005; 8(1): 20–21.CrossRefGoogle ScholarPubMed
Haber, SN. The primate basal ganglia: parallel and integrative networks. J. Chem. Neuroanat. 2003; 26(4): 317–330.CrossRefGoogle Scholar
Crockett, MJ, Apergis-Schoute, A, Herrmann, B, et al. Serotonin modulates striatal responses to fairness and retaliation in humans. J. Neurosci. 2013; 33(8): 3505–3513.CrossRefGoogle Scholar
van de Giessen, E, Rosell, DR, Thompson, JL, et al. Serotonin transporter availability in impulsive aggressive personality disordered patients: a PET study with [(11)C]DASB. J. Psychiatr. Res. 2014; 58: 147–154.CrossRefGoogle Scholar
Malick, JB, Barnett, A. The role of serotonergic pathways in isolation-induced aggression in mice. Pharmacol. Biochem. Behav. 1976; 5(1): 55–61.CrossRefGoogle ScholarPubMed
Brown, GL, Goodwin, FK, Ballenger, JC, Goyer, PF, Major, LF. Aggression in humans correlates with cerebrospinal fluid amine metabolites. Psychiatry Res. 1979; 1(2): 131–139.CrossRefGoogle ScholarPubMed
Brown, GL, Ebert, MH, Goyer, PF, et al. Aggression, suicide, and serotonin: relationships to CSF amine metabolites. Am. J. Psychiatry. 1982; 139(6): 741–746.Google ScholarPubMed
Brown, CS, Kent, TA, Bryant, SG, et al. Blood platelet uptake of serotonin in episodic aggression. Psychiatry Res. 1989; 27(1): 5–12.CrossRefGoogle ScholarPubMed
Stoff, DM, Pollock, L, Vitiello, B, Behar, D, Bridger, WH. Reduction of (3H)-imipramine binding sites on platelets of conduct-disordered children. Neuropsychopharmacology. 1987; 1(1): 55–62.CrossRefGoogle ScholarPubMed
Coccaro, EF, Kavoussi, RJ, Hauger, RL. Physiological responses to d-fenfluramine and ipsapirone challenge correlate with indices of aggression in males with personality disorder. Int. Clin. Psychopharmacol. 1995; 10(3): 177–179.CrossRefGoogle ScholarPubMed
Coccaro, EF, Berman, ME, Kavoussi, RJ, Hauger, RL. Relationship of prolactin response to d-fenfluramine to behavioral and questionnaire assessments of aggression in personality-disordered men. Biol. Psychiatry. 1996; 40(3): 157–164.CrossRefGoogle ScholarPubMed
Coccaro, EF, Kavoussi, RJ, Cooper, TB, Hauger, RL. Central serotonin activity and aggression: inverse relationship with prolactin response to d-fenfluramine, but not CSF 5-HIAA concentration, in human subjects. Am. J. Psychiatry. 1997; 154(10): 1430–1435.Google Scholar
Coccaro, EF, Astill, JL, Herbert, JL, Schut, AG. Fluoxetine treatment of impulsive aggression in DSM-III-R personality disorder patients. J. Clin. Psychopharmacol. 1990; 10(5): 373–375.CrossRefGoogle ScholarPubMed
Coccaro, EF, Kavoussi, RJ. Fluoxetine and impulsive aggressive behavior in personality-disordered subjects. Arch. Gen. Psychiatry. 1997; 54(12): 1081–1088.CrossRefGoogle ScholarPubMed
Kruesi, MJ, Rapoport, JL, Hamburger, S, et al. Cerebrospinal fluid monoamine metabolites, aggression, and impulsivity in disruptive behavior disorders of children and adolescents. Arch. Gen. Psychiatry. 1990; 47(5): 419–426.CrossRefGoogle ScholarPubMed
Coccaro, EF, Lee, R. Cerebrospinal fluid 5-hydroxyindolacetic acid and homovanillic acid: reciprocal relationships with impulsive aggression in human subjects. J. Neural. Transm. 2010; 117(2): 241–248.CrossRefGoogle ScholarPubMed
Coccaro, EF, Kavoussi, RJ, Hauger, RL, Cooper, TB, Ferris, CF. Cerebrospinal fluid vasopressin levels: correlates with aggression and serotonin function in personality-disordered subjects. Arch. Gen. Psychiatry. 1998; 55(8): 708–714.CrossRefGoogle ScholarPubMed
Goveas, JS, Csernansky, JG, Coccaro, EF. Platelet serotonin content correlates inversely with life history of aggression in personality-disordered subjects. Psychiatry Res. 2004; 126(1): 23–32.CrossRefGoogle ScholarPubMed
Coccaro, EF, Kavoussi, RJ, Sheline, YI, Berman, ME, Csernansky, JG. Impulsive aggression in personality disorder correlates with platelet 5-HT2A receptor binding. Neuropsychopharmacology. 1997; 16(3): 211–216.CrossRefGoogle Scholar
Marseille, R, Lee, R, Coccaro, EF. Inter-relationship between different platelet measures of 5-HT and their relationship to aggression in human subjects. Prog. Neuropsychopharmacol. Biol. Psychiatry. 2012; 36(2): 277–281.CrossRefGoogle ScholarPubMed
Modai, I, Gibel, A, Rauchverger, B, et al. Paroxetine binding in aggressive schizophrenic patients. Psychiatry Res. 2000; 94(1): 77–81.CrossRefGoogle ScholarPubMed
Sarne, Y, Mandel, J, Goncalves, MH, et al. Imipramine binding to blood platelets and aggressive behavior in offenders, schizophrenics and normal volunteers. Neuropsychobiology. 1995; 31(3): 120–124.CrossRefGoogle ScholarPubMed
Coccaro, EF, Kavoussi, RJ, Hauger, RL. Serotonin function and antiaggressive response to fluoxetine: a pilot study. Biol. Psychiatry. 1997; 42(7): 546–552.CrossRefGoogle Scholar
Carpenter, LL, Anderson, GM, Pelton, GH, et al. Tryptophan depletion during continuous CSF sampling in healthy human subjects. Neuropsychopharmacology. 1998; 19(1): 26–35.CrossRefGoogle ScholarPubMed
Moreno, FA, McGavin, C, Malan, TP, et al. Tryptophan depletion selectively reduces CSF 5-HT metabolites in healthy young men: results from single lumbar puncture sampling technique. Int. J. Neuropsychopharmacol. 2000; 3(4): 277–283.CrossRefGoogle ScholarPubMed
Williams, WA, Shoaf, SE, Hommer, D, Rawlings, R, Linnoila, M. Effects of acute tryptophan depletion on plasma and cerebrospinal fluid tryptophan and 5-hydroxyindoleacetic acid in normal volunteers. J. Neurochem. 1999; 72(4): 1641–1647.CrossRefGoogle ScholarPubMed
Bjork, JM, Dougherty, DM, Moeller, FG, Cherek, DR, Swann, AC. The effects of tryptophan depletion and loading on laboratory aggression in men: time course and a food-restricted control. Psychopharmacology (Berl). 1999; 142(1): 24–30.CrossRefGoogle Scholar
Bjork, JM, Dougherty, DM, Moeller, FG, Swann, AC. Differential behavioral effects of plasma tryptophan depletion and loading in aggressive and nonaggressive men. Neuropsychopharmacology. 2000; 22(4): 357–369.CrossRefGoogle ScholarPubMed
Kramer, UM, Riba, J, Richter, S, Munte, TF. An fMRI study on the role of serotonin in reactive aggression. PLoS One. 2011; 6(11): e27668.CrossRefGoogle Scholar
Kotting, WF, Bubenzer, S, Helmbold, K, et al. Effects of tryptophan depletion on reactive aggression and aggressive decision-making in young people with ADHD. Acta Psychiatr. Scand. 2013; 128(2): 114–123.CrossRefGoogle ScholarPubMed
Stadler, C, Zepf, FD, Demisch, L, et al. Influence of rapid tryptophan depletion on laboratory-provoked aggression in children with ADHD. Neuropsychobiology. 2007; 56(2–3): 104–110.CrossRefGoogle ScholarPubMed
Zimmermann, M, Grabemann, M, Mette, C, et al. The effects of acute tryptophan depletion on reactive aggression in adults with attention-deficit/hyperactivity disorder (ADHD) and healthy controls. PLoS One. 2012; 7(3): e32023.CrossRefGoogle ScholarPubMed
Fanning, JR, Berman, ME, Guillot, CR, Marsic, A, McCloskey, MS. Serotonin (5-HT) augmentation reduces provoked aggression associated with primary psychopathy traits. J. Pers. Disord. 2014; 28(3): 449–461.CrossRefGoogle ScholarPubMed
Berman, ME, McCloskey, MS, Fanning, JR, Schumacher, JA, Coccaro, EF. Serotonin augmentation reduces response to attack in aggressive individuals. Psychol. Sci. 2009; 20(6): 714–720.CrossRefGoogle ScholarPubMed
Rubia, K, Lee, F, Cleare, AJ, et al. Tryptophan depletion reduces right inferior prefrontal activation during response inhibition in fast, event-related fMRI. Psychopharmacology (Berl). 2005; 179(4): 791–803.CrossRefGoogle ScholarPubMed
Lee, RJ, Gill, A, Chen, B, McCloskey, M, Coccaro, EF. Modulation of central serotonin affects emotional information processing in impulsive aggressive personality disorder. J. Clin. Psychopharmacol. 2012; 32(3): 329–335.CrossRefGoogle Scholar
Grady, CL, Siebner, HR, Hornboll, B, et al. Acute pharmacologically induced shifts in serotonin availability abolish emotion-selective responses to negative face emotions in distinct brain networks. Eur. Neuropsychopharmacol. 2013; 23(5): 368–378.CrossRefGoogle Scholar
Zhang, X, Beaulieu, JM, Sotnikova, TD, Gainetdinov, RR, Caron, MG. Tryptophan hydroxylase-2 controls brain serotonin synthesis. Science. 2004; 305(5681): 217.CrossRefGoogle ScholarPubMed
Osipova, DV, Kulikov, AV, Popova, NK. C1473G polymorphism in mouse tph2 gene is linked to tryptophan hydroxylase-2 activity in the brain, intermale aggression, and depressive-like behavior in the forced swim test. J. Neurosci. Res. 2009; 87(5): 1168–1174.CrossRefGoogle Scholar
Takahashi, A, Shiroishi, T, Koide, T. Genetic mapping of escalated aggression in wild-derived mouse strain MSM/Ms: association with serotonin-related genes. Front. Neurosci. 2014; 8: 156.CrossRefGoogle ScholarPubMed
Mosienko, V, Bert, B, Beis, D, et al. Exaggerated aggression and decreased anxiety in mice deficient in brain serotonin. Transl. Psychiatry. 2012; 2: e122.CrossRefGoogle ScholarPubMed
Chen, GL, Novak, MA, Meyer, JS, et al. The effect of rearing experience and TPH2 genotype on HPA axis function and aggression in rhesus monkeys: a retrospective analysis. Horm. Behav. 2010; 57(2): 184–191.CrossRefGoogle ScholarPubMed
Yang, J, Lee, MS, Lee, SH, et al. Association between tryptophan hydroxylase 2 polymorphism and anger-related personality traits among young Korean women. Neuropsychobiology. 2010; 62(3): 158–163.CrossRefGoogle ScholarPubMed
Yoon, HK, Lee, HJ, Kim, L, Lee, MS, Ham, BJ. Impact of tryptophan hydroxylase 2 G-703T polymorphism on anger-related personality traits and orbitofrontal cortex. Behav. Brain Res. 2012; 231(1): 105–110.CrossRefGoogle ScholarPubMed
Gutknecht, L, Jacob, C, Strobel, A, et al. Tryptophan hydroxylase-2 gene variation influences personality traits and disorders related to emotional dysregulation. Int. J. Neuropsychopharmacol. 2007; 10(3): 309–320.Google ScholarPubMed
Inoue, H, Yamasue, H, Tochigi, M, et al. Effect of tryptophan hydroxylase-2 gene variants on amygdalar and hippocampal volumes. Brain Res. 2010; 1331: 51–57.CrossRefGoogle ScholarPubMed
Perez-Rodriguez, MM, Weinstein, S, New, AS, et al. Tryptophan-hydroxylase 2 haplotype association with borderline personality disorder and aggression in a sample of patients with personality disorders and healthy controls. J. Psychiatr. Res. 2010; 44(15): 1075–1081.CrossRefGoogle Scholar
Brown, SM, Peet, E, Manuck, SB, et al. A regulatory variant of the human tryptophan hydroxylase-2 gene biases amygdala reactivity. Mol. Psychiatry. 2005; 10(9): 884–888.CrossRefGoogle Scholar
Booij, L, Turecki, G, Leyton, M, et al. Tryptophan hydroxylase(2) gene polymorphisms predict brain serotonin synthesis in the orbitofrontal cortex in humans. Mol. Psychiatry. 2012; 17(8): 809–817.CrossRefGoogle ScholarPubMed
Heiming, RS, Monning, A, Jansen, F, et al. To attack, or not to attack? The role of serotonin transporter genotype in the display of maternal aggression. Behav. Brain Res. 2013; 242: 135–141.CrossRefGoogle ScholarPubMed
Holmes, A, Murphy, DL, Crawley, JN. Reduced aggression in mice lacking the serotonin transporter. Psychopharmacology (Berl.). 2002; 161(2): 160–167.CrossRefGoogle ScholarPubMed
Yu, Q, Teixeira, CM, Mahadevia, D, et al. Dopamine and serotonin signaling during two sensitive developmental periods differentially impact adult aggressive and affective behaviors in mice. Mol. Psychiatry. 2014; 19(6): 688–698.CrossRefGoogle ScholarPubMed
Kiryanova, V, Dyck, RH. Increased aggression, improved spatial memory, and reduced anxiety-like behaviour in adult male mice exposed to fluoxetine early in life. Dev. Neurosci. 2014; 36(5): 396–408.CrossRefGoogle ScholarPubMed
Heils, A, Teufel, A, Petri, S, et al. Allelic variation of human serotonin transporter gene expression. J. Neurochem. 1996; 66(6): 2621–2624.CrossRefGoogle ScholarPubMed
May, ME, Lightfoot, DA, Srour, A, Kowalchuk, RK, Kennedy, CH. Association between serotonin transporter polymorphisms and problem behavior in adult males with intellectual disabilities. Brain Res. 2010; 1357: 97–103.CrossRefGoogle ScholarPubMed
Hallikainen, T, Saito, T, Lachman, HM, et al. Association between low activity serotonin transporter promoter genotype and early onset alcoholism with habitual impulsive violent behavior. Mol. Psychiatry. 1999; 4(4): 385–388.CrossRefGoogle ScholarPubMed
Haberstick, BC, Smolen, A, Hewitt, JK. Family-based association test of the 5HTTLPR and aggressive behavior in a general population sample of children. Biol. Psychiatry. 2006; 59(9): 836–843.CrossRefGoogle Scholar
Beitchman, JH, Baldassarra, L, Mik, H, et al. Serotonin transporter polymorphisms and persistent, pervasive childhood aggression. Am. J. Psychiatry. 2006; 163(6): 1103–1105.CrossRefGoogle ScholarPubMed
Verona, E, Joiner, TE, Johnson, F, Bender, TW. Gender specific gene-environment interactions on laboratory-assessed aggression. Biol. Psychol. 2006; 71(1): 33–41.CrossRefGoogle ScholarPubMed
Conway, CC, Keenan-Miller, D, Hammen, C, et al. Coaction of stress and serotonin transporter genotype in predicting aggression at the transition to adulthood. J. Clin. Child Adolesc. Psychol. 2012; 41(1): 53–63.CrossRefGoogle ScholarPubMed
Reif, A, Rosler, M, Freitag, CM, et al. Nature and nurture predispose to violent behavior: serotonergic genes and adverse childhood environment. Neuropsychopharmacology. 2007; 32(11): 2375–2383.CrossRefGoogle ScholarPubMed
Aluja, A, Garcia, LF, Blanch, A, De, LD, Fibla, J. Impulsive-disinhibited personality and serotonin transporter gene polymorphisms: association study in an inmate’s sample. J. Psychiatr. Res. 2009; 43(10): 906–914.CrossRefGoogle Scholar
Payer, DE, Nurmi, EL, Wilson, SA, McCracken, JT, London, ED. Effects of methamphetamine abuse and serotonin transporter gene variants on aggression and emotion-processing neurocircuitry. Transl. Psychiatry. 2012; 2: e80.CrossRefGoogle ScholarPubMed
Philibert, R, Madan, A, Andersen, A, et al. Serotonin transporter mRNA levels are associated with the methylation of an upstream CpG island. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007; 144B(1): 101–105.CrossRefGoogle ScholarPubMed
Koenen, KC, Uddin, M, Chang, SC, et al. SLC6A4 methylation modifies the effect of the number of traumatic events on risk for posttraumatic stress disorder. Depress. Anxiety. 2011; 28(8): 639–647.CrossRefGoogle ScholarPubMed
Zhao, J, Goldberg, J, Bremner, JD, Vaccarino, V. Association between promoter methylation of serotonin transporter gene and depressive symptoms: a monozygotic twin study. Psychosom. Med. 2013; 75(6): 523–529.CrossRefGoogle ScholarPubMed
Dannlowski, U, Kugel, H, Redlich, R, et al. Serotonin transporter gene methylation is associated with hippocampal gray matter volume. Hum. Brain Mapp. 2014; 35(11): 5356–5367.CrossRefGoogle ScholarPubMed
Nikolova, YS, Koenen, KC, Galea, S, et al. Beyond genotype: serotonin transporter epigenetic modification predicts human brain function. Nat. Neurosci. 2014; 17(9): 1153–1155.CrossRefGoogle ScholarPubMed
Wang, D, Szyf, M, Benkelfat, C, et al. Peripheral SLC6A4 DNA methylation is associated with in vivo measures of human brain serotonin synthesis and childhood physical aggression. PLoS One. 2012; 7(6): e39501.CrossRefGoogle Scholar
Frankle, WG, Lombardo, I, New, AS, et al. Brain serotonin transporter distribution in subjects with impulsive aggressivity: a positron emission study with [11C]McN 5652. Am. J. Psychiatry. 2005; 162(5): 915–923.CrossRefGoogle ScholarPubMed
Bortolato, M, Chen, K, Shih, JC. Monoamine oxidase inactivation: from pathophysiology to therapeutics. Adv. Drug Deliv. Rev. 2008; 60(13–14): 1527–1533.CrossRefGoogle ScholarPubMed
Brunner, HG, Nelen, M, Breakefield, XO, Ropers, HH, van Oost, BA. Abnormal behavior associated with a point mutation in the structural gene for monoamine oxidase A. Science. 1993; 262(5133): 578–580.CrossRefGoogle ScholarPubMed
Sabol, SZ, Hu, S, Hamer, D. A functional polymorphism in the monoamine oxidase A gene promoter. Hum. Genet. 1998; 103(3): 273–279.CrossRefGoogle ScholarPubMed
Kuepper, Y, Grant, P, Wielpuetz, C, Hennig, J. MAOA-uVNTR genotype predicts interindividual differences in experimental aggressiveness as a function of the degree of provocation. Behav. Brain Res. 2013; 247: 73–78.CrossRefGoogle ScholarPubMed
Manuck, SB, Flory, JD, Ferrell, RE, Mann, JJ, Muldoon, MF. A regulatory polymorphism of the monoamine oxidase-A gene may be associated with variability in aggression, impulsivity, and central nervous system serotonergic responsivity. Psychiatry Res. 2000; 95(1): 9–23.CrossRefGoogle ScholarPubMed
Stetler, DA, Davis, C, Leavitt, K, et al. Association of low-activity MAOA allelic variants with violent crime in incarcerated offenders. J. Psychiatr. Res. 2014; 58: 69–75.CrossRefGoogle ScholarPubMed
Byrd, AL, Manuck, SB. MAOA, childhood maltreatment, and antisocial behavior: meta-analysis of a gene-environment interaction. Biol. Psychiatry. 2014; 75(1): 9–17.CrossRefGoogle ScholarPubMed
Karere, GM, Kinnally, EL, Sanchez, JN, et al. What is an “adverse” environment? Interactions of rearing experiences and MAOA genotype in rhesus monkeys. Biol. Psychiatry. 2009; 65(9): 770–777.CrossRefGoogle Scholar
Newman, TK, Syagailo, YV, Barr, CS, et al. Monoamine oxidase A gene promoter variation and rearing experience influences aggressive behavior in rhesus monkeys. Biol. Psychiatry. 2005; 57(2): 167–172.CrossRefGoogle ScholarPubMed
Alia-Klein, N, Goldstein, RZ, Kriplani, A, et al. Brain monoamine oxidase A activity predicts trait aggression. J. Neurosci. 2008; 28(19): 5099–5104.CrossRefGoogle ScholarPubMed
Cases, O, Seif, I, Grimsby, J, et al. Aggressive behavior and altered amounts of brain serotonin and norepinephrine in mice lacking MAOA. Science. 1995; 268(5218): 1763–1766.CrossRefGoogle ScholarPubMed
Scott, AL, Bortolato, M, Chen, K, Shih, JC. Novel monoamine oxidase A knock out mice with human-like spontaneous mutation. Neuroreport. 2008; 19(7): 739–743.CrossRefGoogle ScholarPubMed
Cases, O, Vitalis, T, Seif, I, et al. Lack of barrels in the somatosensory cortex of monoamine oxidase A-deficient mice: role of a serotonin excess during the critical period. Neuron. 1996; 16(2): 297–307.CrossRefGoogle ScholarPubMed
Bortolato, M, Godar, SC, Tambaro, S, et al. Early postnatal inhibition of serotonin synthesis results in long-term reductions of perseverative behaviors, but not aggression, in MAO A-deficient mice. Neuropharmacology. 2013; 75: 223–232.CrossRefGoogle Scholar
Garcia-Garcia, AL, Newman-Tancredi, A, Leonardo, ED. 5-HT(1A) [corrected] receptors in mood and anxiety: recent insights into autoreceptor versus heteroreceptor function. Psychopharmacology (Berl.). 2014; 231(4): 623–636.CrossRefGoogle Scholar
Polter, AM, Li, X. 5-HT1A receptor-regulated signal transduction pathways in brain. Cell Signal. 2010; 22(10): 1406–1412.CrossRefGoogle ScholarPubMed
Miczek, KA, Hussain, S, Faccidomo, S. Alcohol-heightened aggression in mice: attenuation by 5-HT1A receptor agonists. Psychopharmacology (Berl.). 1998; 139(1–2): 160–168.CrossRefGoogle ScholarPubMed
Pruus, K, Skrebuhhova-Malmros, T, Rudissaar, R, Matto, V, Allikmets, L. 5-HT1A receptor agonists buspirone and gepirone attenuate apomorphine-induced aggressive behaviour in adult male Wistar rats. J. Physiol. Pharmacol. 2000; 51(4 Pt 2): 833–846.Google ScholarPubMed
Centenaro, LA, Vieira, K, Zimmermann, N, et al. Social instigation and aggressive behavior in mice: role of 5-HT1A and 5-HT1B receptors in the prefrontal cortex. Psychopharmacology (Berl.). 2008; 201(2): 237–248.CrossRefGoogle Scholar
da Veiga, CP, Miczek, KA, Lucion, AB, de Almeida, RM. Social instigation and aggression in postpartum female rats: role of 5-Ht1A and 5-Ht1B receptors in the dorsal raphe nucleus and prefrontal cortex. Psychopharmacology (Berl.). 2011; 213(2–3): 475–487.CrossRefGoogle ScholarPubMed
de Boer, SF, Lesourd, M, Mocaer, E, Koolhaas, JM. Somatodendritic 5-HT(1A) autoreceptors mediate the anti-aggressive actions of 5-HT(1A) receptor agonists in rats: an ethopharmacological study with S-15535, alnespirone, and WAY-100635. Neuropsychopharmacology. 2000; 23(1): 20–33.CrossRefGoogle ScholarPubMed
Stein, DJ, Miczek, KA, Lucion, AB, de Almeida, RM. Aggression-reducing effects of F15599, a novel selective 5-HT1A receptor agonist, after microinjection into the ventral orbital prefrontal cortex, but not in infralimbic cortex in male mice. Psychopharmacology (Berl.). 2013; 230(3): 375–387.CrossRefGoogle Scholar
Naumenko, VS, Kozhemyakina, RV, Plyusnina, IF, Kulikov, AV, Popova, NK. Serotonin 5-HT1A receptor in infancy-onset aggression: comparison with genetically defined aggression in adult rats. Behav. Brain Res. 2013; 243: 97–101.CrossRefGoogle ScholarPubMed
Popova, NK, Naumenko, VS, Plyusnina, IZ, Kulikov, AV. Reduction in 5-HT1A receptor density, 5-HT1A mRNA expression, and functional correlates for 5-HT1A receptors in genetically defined aggressive rats. J. Neurosci. Res. 2005; 80(2): 286–292.CrossRefGoogle ScholarPubMed
Popova, NK, Naumenko, VS, Plyusnina, IZ. Involvement of brain serotonin 5-HT1A receptors in genetic predisposition to aggressive behavior. Neurosci. Behav. Physiol. 2007; 37(6): 631–635.CrossRefGoogle ScholarPubMed
van der Vegt, BJ, de Boer, SF, Buwalda, B, et al. Enhanced sensitivity of postsynaptic serotonin-1A receptors in rats and mice with high trait aggression. Physiol. Behav. 2001; 74(1–2): 205–211.CrossRefGoogle ScholarPubMed
Audero, E, Mlinar, B, Baccini, G, et al. Suppression of serotonin neuron firing increases aggression in mice. J. Neurosci. 2013; 33(20): 8678–8688.CrossRefGoogle ScholarPubMed
Almeida, M, Lee, R, Coccaro, EF. Cortisol responses to ipsapirone challenge correlate with aggression, while basal cortisol levels correlate with impulsivity, in personality disorder and healthy volunteer subjects. J. Psychiatr. Res. 2010; 44(14): 874–880.CrossRefGoogle ScholarPubMed
Coccaro, EF, Gabriel, S, Siever, LJ. Buspirone challenge: preliminary evidence for a role for central 5-HT1a receptor function in impulsive aggressive behavior in humans. Psychopharmacol. Bull. 1990; 26(3): 393–405.Google ScholarPubMed
Benko, A, Lazary, J, Molnar, E, et al. Significant association between the C(-1019)G functional polymorphism of the HTR1A gene and impulsivity. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010; 153B(2): 592–599.CrossRefGoogle Scholar
Joyce, PR, Stephenson, J, Kennedy, M, Mulder, RT, McHugh, PC. The presence of both serotonin 1A receptor (HTR1A) and dopamine transporter (DAT1) gene variants increase the risk of borderline personality disorder. Front. Genet. 2014; 4: 313.CrossRefGoogle Scholar
Witte, AV, Floel, A, Stein, P, et al. Aggression is related to frontal serotonin-1A receptor distribution as revealed by PET in healthy subjects. Hum. Brain Mapp. 2009; 30(8): 2558–2570.CrossRefGoogle ScholarPubMed
Parsey, RV, Oquendo, MA, Simpson, NR, et al. Effects of sex, age, and aggressive traits in man on brain serotonin 5-HT1A receptor binding potential measured by PET using [C-11]WAY-100635. Brain Res. 2002; 954(2): 173–182.CrossRefGoogle Scholar
Sari, Y. Serotonin1B receptors: from protein to physiological function and behavior. Neurosci. Biobehav. Rev. 2004; 28(6): 565–582.CrossRefGoogle ScholarPubMed
Bannai, M, Fish, EW, Faccidomo, S, Miczek, KA. Anti-aggressive effects of agonists at 5-HT1B receptors in the dorsal raphe nucleus of mice. Psychopharmacology (Berl.). 2007; 193(2): 295–304.CrossRefGoogle ScholarPubMed
de Almeida, RM, Miczek, KA. Aggression escalated by social instigation or by discontinuation of reinforcement (“frustration”) in mice: inhibition by anpirtoline: a 5-HT1B receptor agonist. Neuropsychopharmacology. 2002; 27(2): 171–181.CrossRefGoogle ScholarPubMed
de Almeida, RM, Rosa, MM, Santos, DM, et al. 5-HT(1B) receptors, ventral orbitofrontal cortex, and aggressive behavior in mice. Psychopharmacology (Berl.). 2006; 185(4): 441–450.CrossRefGoogle ScholarPubMed
Faccidomo, S, Bannai, M, Miczek, KA. Escalated aggression after alcohol drinking in male mice: dorsal raphe and prefrontal cortex serotonin and 5-HT(1B) receptors. Neuropsychopharmacology. 2008; 33(12): 2888–2899.CrossRefGoogle ScholarPubMed
Faccidomo, S, Quadros, IM, Takahashi, A, Fish, EW, Miczek, KA. Infralimbic and dorsal raphe microinjection of the 5-HT(1B) receptor agonist CP-93,129: attenuation of aggressive behavior in CFW male mice. Psychopharmacology (Berl.). 2012; 222(1): 117–128.CrossRefGoogle ScholarPubMed
Fish, EW, Faccidomo, S, Miczek, KA. Aggression heightened by alcohol or social instigation in mice: reduction by the 5-HT(1B) receptor agonist CP-94,253. Psychopharmacology (Berl.). 1999; 146(4): 391–399.CrossRefGoogle ScholarPubMed
Fish, EW, McKenzie-Quirk, SD, Bannai, M, Miczek, KA. 5-HT(1B) receptor inhibition of alcohol-heightened aggression in mice: comparison to drinking and running. Psychopharmacology (Berl.). 2008; 197(1): 145–156.CrossRefGoogle ScholarPubMed
Veiga, CP, Miczek, KA, Lucion, AB, Almeida, RM. Effect of 5-HT1B receptor agonists injected into the prefrontal cortex on maternal aggression in rats. Braz. J. Med. Biol. Res. 2007; 40(6): 825–830.CrossRefGoogle Scholar
Ramboz, S, Saudou, F, Amara, DA, et al. 5-HT1B receptor knock out—behavioral consequences. Behav. Brain Res. 1996; 73(1–2): 305–312.CrossRefGoogle ScholarPubMed
Bouwknecht, JA, Hijzen, TH, van der Gugten, J, et al. Absence of 5-HT(1B) receptors is associated with impaired impulse control in male 5-HT(1B) knockout mice. Biol. Psychiatry. 2001; 49(7): 557–568.CrossRefGoogle ScholarPubMed
Conner, TS, Jensen, KP, Tennen, H, et al. Functional polymorphisms in the serotonin 1B receptor gene (HTR1B) predict self-reported anger and hostility among young men. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2010; 153B(1): 67–78.Google Scholar
Hakulinen, C, Jokela, M, Hintsanen, M, et al. Serotonin receptor 1B genotype and hostility, anger and aggressive behavior through the lifespan: the Young Finns study. J. Behav. Med. 2013; 36(6): 583–590.CrossRefGoogle ScholarPubMed
Jensen, KP, Covault, J, Conner, TS, et al. A common polymorphism in serotonin receptor 1B mRNA moderates regulation by miR-96 and associates with aggressive human behaviors. Mol. Psychiatry. 2009; 14(4): 381–389.CrossRefGoogle ScholarPubMed
Zouk, H, McGirr, A, Lebel, V, et al. The effect of genetic variation of the serotonin 1B receptor gene on impulsive aggressive behavior and suicide. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2007; 144B(8): 996–1002.CrossRefGoogle ScholarPubMed
Potenza, MN, Walderhaug, E, Henry, S, et al. Serotonin 1B receptor imaging in pathological gambling. World J. Biol. Psychiatry. 2013; 14(2): 139–145.CrossRefGoogle ScholarPubMed
Hu, J, Henry, S, Gallezot, JD, et al. Serotonin 1B receptor imaging in alcohol dependence. Biol. Psychiatry. 2010; 67(9): 800–803.CrossRefGoogle ScholarPubMed
Murrough, JW, Henry, S, Hu, J, et al. Reduced ventral striatal/ ventral pallidal serotonin1B receptor binding potential in major depressive disorder. Psychopharmacology (Berl.). 2011; 213(2–3): 547–553.CrossRefGoogle Scholar
Higgins, GA, Enderlin, M, Haman, M, Fletcher, PJ. The 5-HT2A receptor antagonist M100,907 attenuates motor and ‘impulsive-type’ behaviours produced by NMDA receptor antagonism. Psychopharmacology (Berl.). 2003; 170(3): 309–319.CrossRefGoogle ScholarPubMed
Sakaue, M, Ago, Y, Sowa, C, et al. Modulation by 5-hT2A receptors of aggressive behavior in isolated mice. Jpn J. Pharmacol. 2002; 89(1): 89–92.CrossRefGoogle ScholarPubMed
Winstanley, CA, Theobald, DE, Dalley, JW, Glennon, JC, Robbins, TW. 5-HT2A and 5-HT2C receptor antagonists have opposing effects on a measure of impulsivity: interactions with global 5-HT depletion. Psychopharmacology (Berl.). 2004; 176(3–4): 376–385.CrossRefGoogle ScholarPubMed
Giegling, I, Hartmann, AM, Moller, HJ, Rujescu, D. Anger- and aggression-related traits are associated with polymorphisms in the 5-HT-2A gene. J. Affect. Disord. 2006; 96(1–2): 75–81.CrossRefGoogle Scholar
Bruce, KR, Steiger, H, Joober, R, et al. Association of the promoter polymorphism -1438G/A of the 5-HT2A receptor gene with behavioral impulsiveness and serotonin function in women with bulimia nervosa. Am. J. Med. Genet. B Neuropsychiatr. Genet. 2005; 137B(1): 40–44.CrossRefGoogle ScholarPubMed
Jakubczyk, A, Wrzosek, M, Lukaszkiewicz, J, et al. The CC genotype in HTR2A T102C polymorphism is associated with behavioral impulsivity in alcohol-dependent patients. J. Psychiatr. Res. 2012; 46(1): 44–49.CrossRefGoogle Scholar
Jakubczyk, A, Klimkiewicz, A, Kopera, M, et al. The CC genotype in the T102C HTR2A polymorphism predicts relapse in individuals after alcohol treatment. J. Psychiatr. Res. 2013; 47(4): 527–533.CrossRefGoogle Scholar
Preuss, UW, Koller, G, Bondy, B, Bahlmann, M, Soyka, M. Impulsive traits and 5-HT2A receptor promoter polymorphism in alcohol dependents: possible association but no influence of personality disorders. Neuropsychobiology. 2001; 43(3): 186–191.CrossRefGoogle ScholarPubMed
Tsuang, HC, Chen, WJ, Lin, SH, et al. Impaired impulse control is associated with a 5-HT2A receptor polymorphism in schizophrenia. Psychiatry Res. 2013; 208(2): 105–110.CrossRefGoogle Scholar
Bjork, JM, Moeller, FG, Dougherty, DM, et al. Serotonin 2a receptor T102C polymorphism and impaired impulse control. Am. J. Med. Genet. 2002; 114(3): 336–339.CrossRefGoogle ScholarPubMed
Oquendo, MA, Russo, SA, Underwood, MD, et al. Higher postmortem prefrontal 5-HT2A receptor binding correlates with lifetime aggression in suicide. Biol. Psychiatry. 2006; 59(3): 235–243.CrossRefGoogle Scholar
Dwivedi, Y, Mondal, AC, Payappagoudar, GV, Rizavi, HS. Differential regulation of serotonin (5HT)2A receptor mRNA and protein levels after single and repeated stress in rat brain: role in learned helplessness behavior. Neuropharmacology. 2005; 48(2): 204–214.CrossRefGoogle ScholarPubMed
Soloff, PH, Chiappetta, L, Mason, NS, Becker, C, Price, JC. Effects of serotonin-2A receptor binding and gender on personality traits and suicidal behavior in borderline personality disorder. Psychiatry Res. 2014; 222(3): 140–148.CrossRefGoogle Scholar
Meyer, JH, Wilson, AA, Rusjan, P, et al. Serotonin2A receptor binding potential in people with aggressive and violent behaviour. J. Psychiatry Neurosci. 2008; 33(6): 499–508.Google ScholarPubMed
Rylands, AJ, Hinz, R, Jones, M, et al. Pre- and postsynaptic serotonergic differences in males with extreme levels of impulsive aggression without callous unemotional traits: a positron emission tomography study using (11)C-DASB and (11)C-MDL100907. Biol. Psychiatry. 2012; 72(12): 1004–1011.CrossRefGoogle ScholarPubMed
Chameau, P, van Hooft, JA. Serotonin 5-HT(3) receptors in the central nervous system. Cell Tissue Res. 2006; 326(2): 573–581.CrossRefGoogle ScholarPubMed
De Deurwaerdère, P, Moison, D, Navailles, S, Porras, G, Spampinato, U. Regionally and functionally distinct serotonin3 receptors control in vivo dopamine outflow in the rat nucleus accumbens. J. Neurochem. 2005; 94(1): 140–149.CrossRefGoogle ScholarPubMed
Cervantes, MC, Delville, Y. Serotonin 5-HT1A and 5-HT3 receptors in an impulsive-aggressive phenotype. Behav. Neurosci. 2009; 123(3): 589–598.CrossRefGoogle Scholar
Ricci, LA, Grimes, JM, Melloni, RH Jr. Serotonin type 3 receptors modulate the aggression-stimulating effects of adolescent cocaine exposure in Syrian hamsters (Mesocricetus auratus). Behav. Neurosci. 2004; 118(5): 1097–1110.CrossRefGoogle Scholar
Ricci, LA, Knyshevski, I, Melloni, RH Jr. Serotonin type 3 receptors stimulate offensive aggression in Syrian hamsters. Behav. Brain Res. 2005; 156(1): 19–29.CrossRefGoogle ScholarPubMed
Rudissaar, R, Pruus, K, Skrebuhhova, T, Allikmets, L, Matto, V. Modulatory role of 5-HT3 receptors in mediation of apomorphine-induced aggressive behaviour in male rats. Behav. Brain Res. 1999; 106(1–2): 91–96.CrossRefGoogle ScholarPubMed
McKenzie-Quirk, SD, Girasa, KA, Allan, AM, Miczek, KA. 5-HT(3) receptors, alcohol and aggressive behavior in mice. Behav. Pharmacol. 2005; 16(3): 163–169.CrossRefGoogle ScholarPubMed
Sellers, EM, Toneatto, T, Romach, MK, et al. Clinical efficacy of the 5-HT3 antagonist ondansetron in alcohol abuse and dependence. Alcohol Clin. Exp. Res. 1994; 18(4): 879–885.CrossRefGoogle ScholarPubMed
Johnson, BA, Ait-Daoud, N, Ma, JZ, Wang, Y. Ondansetron reduces mood disturbance among biologically predisposed, alcohol-dependent individuals. Alcohol Clin. Exp. Res. 2003; 27(11): 1773–1779.CrossRefGoogle ScholarPubMed
Myrick, H, Anton, RF, Li, X, et al. Effect of naltrexone and ondansetron on alcohol cue-induced activation of the ventral striatum in alcohol-dependent people. Arch. Gen. Psychiatry. 2008; 65(4): 466–475.CrossRefGoogle Scholar
Ducci, F, Enoch, MA, Yuan, Q, et al. HTR3B is associated with alcoholism with antisocial behavior and alpha EEG power—an intermediate phenotype for alcoholism and co-morbid behaviors. Alcohol. 2009; 43(1): 73–84.CrossRefGoogle Scholar
Melke, J, Westberg, L, Nilsson, S, et al. A polymorphism in the serotonin receptor 3A (HTR3A) gene and its association with harm avoidance in women. Arch. Gen. Psychiatry. 2003; 60(10): 1017–1023.CrossRefGoogle ScholarPubMed
Gatt, JM, Williams, LM, Schofield, PR, et al. Impact of the HTR3A gene with early life trauma on emotional brain networks and depressed mood. Depress. Anxiety. 2010; 27(8): 752–759.CrossRefGoogle ScholarPubMed
Iidaka, T, Ozaki, N, Matsumoto, A, et al. A variant C178T in the regulatory region of the serotonin receptor gene HTR3A modulates neural activation in the human amygdala. J. Neurosci. 2005; 25(27): 6460–6466.CrossRefGoogle ScholarPubMed
Schlüter, T, Winz, O, Henkel, K, et al. The impact of dopamine on aggression: an [18F]-FDOPA PET Study in healthy males. J. Neurosci. 2013; 33(43): 16, 889–16, 896.CrossRefGoogle Scholar